Stem Cell-based therapies for COVID-19-related acute respiratory distress syndrome.

ABSTRACT: As the number of confirmed cases and resulting death toll of the COVID-19 pandemic continue to increase around the globe - especially with the emergence of new mutations of the SARS-CoV-2 virus in addition to the known alpha, beta, gamma, delta and omicron variants - tremendous efforts continue to be dedicated to the development of interventive therapeutics to mitigate infective symptoms or post-viral sequelae in individuals for which vaccines are not accessible, viable or effective in the prevention of illness. Many of these investigations aim to target the associated acute respiratory distress syndrome, or ARDS, which induces damage to lung epithelia and other physiologic systems and is associated with progression in severe cases. Recently, stem cell-based therapies have demonstrated pre

SUBMITTER: Ngai HW 

PROVIDER: S-EPMC9077311 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature